| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Research and Development | EVP, Research &Development | Cso/ EVP Disc &Trans Research
1 company
Aftab Dana serves as an EVP, Research and Development at EXEL. Across recent SEC filings that breaks down to 0 buys and 13 sells. Those positions are worth an estimated $29.9M at current prices.
Historically, Aftab Dana's trades have earned a below-average insider score of 41/100 across 13 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -24.5%.
The biggest single holding is EXEL (~$29.9M) as EVP, Research and Development. The recent filings there lean toward selling, a net 499,251 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | EXEL Exelixis, Inc. | EVP, Research and Development | Sell | 43,451 | $50.35 | $2,187,757.85 | -6.8% | +9.1% | - | |
| Feb 24, 2026 | EXEL Exelixis, Inc. | EVP, Research and Development | Sell | 47,918 | $44.50 | $2,132,351.00 | -7.2% | +10.7% | - | |
| Feb 19, 2026 | EXEL Exelixis, Inc. | EVP, Research and Development | Sell | 29,873 | $44.35 | $1,324,867.55 | -4.3% | +13.0% | - | |
| Nov 11, 2025 | EXEL Exelixis, Inc. | EVP, Research and Development | Sell | 48,383 | $42.50 | $2,056,277.50 | -6.8% | +2.3% | - | |
| May 1, 2025 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sell10b5-1 | 1,508 | $39.00 | $58,812.00 | -0.2% | -5.2% | +12.3% | |
| Feb 24, 2025 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sell | 26,987 | $36.75 | $991,772.25 | -5.0% | +16.1% | +21.6% | |
| Nov 5, 2024 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sale+OE10b5-1 | 96,986 | $35.00 | $3,394,510.00 | -16.3% | -5.4% | +16.1% | |
| Oct 30, 2024 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sell10b5-1 | 1,162 | $31.40 | $36,486.80 | -0.2% | +0.5% | +20.0% | |
| Aug 12, 2024 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sell | 20,883 | $27.06 | $565,093.98 | -4.0% | +34.4% | +40.9% | |
| Aug 7, 2024 | EXEL Exelixis, Inc. | Cso/ EVP Disc &Trans Research | Sale+OE10b5-1 | 95,000 | $25.00 | $2,375,000.00 | -15.4% | +31.1% | +41.0% |